BioRegio Rhein-Main Company Profile

21:08 EST 19th November 2017 | BioPortfolio

Consultancy and technology transfer services for the University of Mainz. Emphasis placed on genomics, microbiology, genetic engineering, cellular biology and biochemistry.


Duesbergweg 6


Phone: 49 61 31 39 52 00
Fax: 00 49 61 31 39 52 00

News Articles [35 Associated News Articles listed on BioPortfolio]

Katena Products acquires Rhein Medical

Katena Products has acquired Rhein Medical, according to a company press release.Rhein Medical has been focused on the anterior segment surgical business, including instruments for cataract and refrac...

Katena buys Rhein Medical

Katena Products Inc. is acquiring fellow closely held ophthalmic device maker Rhein Medical Inc. for an undisclosed sum.

Katena Products Announces the Acquisition of Rhein Medical, Inc.

Katena Products ("Katena"), a leading global provider of precision ophthalmic instruments, biologics, and devices to hospitals, surgical centers, and ophthalmic and optometric off...


Tous les jours un bref écho des principales infos de la veille avec le remindHIER de BiotechFinances Eurobiomed, le pôle de compétitivité santé PACA Languedoc-Roussillon et l’Afssi, l̵...

Global TBzTD CAS 10591852 Market Data Survey Report 2025 [Report Updated: 01011970] Prices from USD $1500

SummaryTBzTD is a safe, green secondary amine accelerator, which can be used as fast curing primary accelerator or as secondary accelerator. TBzTD has been widely used in natural rubber, styrenebutadi...

Castle Creek Pharmaceuticals Announces First IGA Scale for Epidermolysis Bullosa Simplex Clinical Research

PARSIPPANY, N.J., Sept. 27, 2017 /PRNewswire/ -- Castle Creek Pharmaceuticals (CCP), a global company dedicated to delivering transformative therapies to patients with orphan dermatologic and other un...

PATHWAY-2 uncovers main cause of drug-resistant hypertension, finds old drugs work best

Salt retention is the main culprit behind drug-resistant hypertension (RHTN), with older diuretic medications being the most effective treatment, according to new results from the PATHWAY-2 study.

Four main genes linked to survival of pancreatic cancer patients

Alterations in four main genes are responsible for how long patients survive with pancreatic cancer, according to a new study in JAMA Oncology.

PubMed Articles [228 Associated PubMed Articles listed on BioPortfolio]

The natural agent rhein induces β-catenin degradation and tumour growth arrest.

The natural agent rhein is an ananthraquinone derivative of rhubarb, which has anticancer effects. To determine the mechanisms underlying the anticancer effects of rhein, we detected the effect of rhe...

Rhein ameliorates adenomyosis by inhibiting NF-κB and β-Catenin signaling pathway.

In the present study, we examined the effects of rhein on pituitary gland implantation-induced adenomyosis, an animal model which mimics human adenomyosis. Oral administration of rhein dose-dependentl...

Preparation, characterization, and in vivo study of Rhein Solid Lipid Nanoparticles for oral delivery.

In this study, rhein-SLNs were successfully produced by hot homogenization followed by ultrasonication. Precirol ATO5 in which Rhein exhibited higher partition coefficient was selected for preparation...

Simultaneous Determination of Seven Anthraquinone Aglycones of Crude and Processed Semen Cassiae Extracts in Rat Plasma by UPLC-MS/MS and Its Application to a Comparative Pharmacokinetic Study.

Semen cassiae is the ripe seed of Cassia obtusifolia L. or Cassia tora L. of the family Leguminosae. In traditional Chinese medicine, the two forms of Semen cassiae are raw Semen cassiae (R-SC) and pa...

Biodegradable nanoparticles for improved kidney bioavailability of rhein: preparation, characterization, plasma and kidney pharmacokinetics.

The aim of this work is to develop biodegradable nanoparticles for improved kidney bioavailability of rhein (RH). RH-loaded nanoparticles were prepared using an emulsification solvent evaporation meth...

Clinical Trials [1377 Associated Clinical Trials listed on BioPortfolio]

Schlaganfallkonsortium Rhein-Neckar (Stroke Consortium Rhine-Neckar)

FAST is an investigator-initiated multicenter study embedded in a German multistate acute stroke network. The main objectives of the FAST study are to improve outcomes and quality of care ...

Genetic Basis of Odor Discrimination

Prior to the main study we will perform a pilot study on 60 subjects. The purpose of the pilot study is to identify the range of odor concentrations that will be used in the main study and...

Clinical Study to Evaluate the STENTYS Xposition S for Treatment of Unprotected Left Main Coronary Artery Disease

Prospective, non-randomized, multi-center study assessing the long term safety and efficacy of the self expandable sirolimus eluting Xposition S stent in the treatment of unprotected left ...

Randomized Comparison of Ultrasound Versus Radiofrequency Denervation in Patients With Therapy Resistant Hypertension

Prospective, randomized trial to assess the effectiveness of different renal sympathetic denervation methods (radiofrequency main vs. branches + main vs. ultrasound based) in a cohort of p...

Comparison of Coronary Wedge Pressure and Collateral Flow Index Between Main Branch and Side Branch Vessels

The purpose of this trial is to compare the degree of collateral flow in the main vessel and the side branch vessel. Specifically, the trial will address the superiority of the recruitable...

Companies [442 Associated Companies listed on BioPortfolio]

BioRegio Rhein-Main

Consultancy and technology transfer services for the University of Mainz. Emphasis placed on genomics, microbiology, genetic engineering, cellular biology and biochemistry.

BioRegio Jena e.V.,

The venerable Senate hall of the Alma Mater Jenensis can safely be called the cradle of our association BioRegio Jena e.V. It was here that in the late summer of 1995 about 15 to 20 biologists, physic...

Rhein Biotech N.V.

Rhein Biotech is a globally active biotech company and the world's third largest hepatitis B vaccine manufacturer. Berna Biotech, a fully integrated vaccine focused biotechnology company acquired 92.2...

BioCon Valley® GmbH

Born out of Germany´s "BioRegio" competition in 1996 BioCon Valley represents an interdisciplinary network in the field of modern life sciences and health care.Universities, research and health care ...

Main Drug Mart.

Mr. Souren Agemian, founder and president of Main Drug Mart, has laboured very diligently since 1968 to acquire the trust and confidence of his patients. As such, Main Drug Mart's reputation was quick...

More Information about "BioRegio Rhein-Main" on BioPortfolio

We have published hundreds of BioRegio Rhein-Main news stories on BioPortfolio along with dozens of BioRegio Rhein-Main Clinical Trials and PubMed Articles about BioRegio Rhein-Main for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of BioRegio Rhein-Main Companies in our database. You can also find out about relevant BioRegio Rhein-Main Drugs and Medications on this site too.

Quick Search

Corporate Database Quicklinks

Searches Linking to this Company Record